Catalyst Wire Dossier Catalyst Wire Dossier

GSK561679

GSK561679 · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for GSK561679, covering 2010-10-19 to 2017-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder [Phase 2]

See pricing